Journals / Journal of Neurological Sciences (Turkish) / 2012 / Cilt: 29 - Sayı: 3

Akut Subaraknoid Kanama Sırasında (<72 saat) Serebral Anevrizmaların Endovasküler Tedavisi

Endovascular Treatment of Cerebral Aneurysms During Acute (<72 Hours) Subarachnoid Hemorrhage

Pages
535–541
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Delayed rebleeding is possible after endovasculartreatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the safety and efficacy of endovascular embolization of rupturedcerebral aneurysms during acute stage of subarachnoid hemorrhage (SAH).Methods: Results in 40 consecutive patients (14men, 26women; mean age, 50.9years; range,34 72 years) with acutely ruptured cerebral aneurysms who were treated with endovascularcoil embolization were evaluated.
📊
Key Findings & Data:The mean length of angiographic follow-up was 8.8 months(range, 3 18 months).Results: Forty-four aneurysms were treated endovascularly in 40 patients.
💡
Conclusion & Impact:Delayed rebleeding is possible after endovasculartreatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the safety and efficacy of endovascular embolization of rupturedcerebral aneurysms during acute stage of subarachnoid hemorrhage (SAH).Methods: Results in 40 consecutive patients (14men, 26women; mean age, 50.9years; range,34 72 years) with acutely ruptured cerebral aneurysms who were treated with endovascularcoil embolization were evaluated. The mean length of angiographic follow-up was 8.8 months(range, 3 18 months).Results: Forty-four aneurysms were treated endovascularly in 40 patients. The technicalsuccess rate was 97.7% (43 of 44). There were 2 (4.5%) cases of intraprocedural bleeding,which caused 1 death. There was 1 (2.5%) case of rebleeding causing death within 24 hoursafter endovascular embolization, and clinical outcome was good for 92.5% patients hadGlasgow Outcome Scale scores of 4 or 5 at the end of the study period.Conclusion: Endovascular coil embolization is a safe method for cerebral aneurysms that aredifficult to treat surgically during acute SAH. Intraprocedural bleeding is the main adverseevent associated with this treatment. Delayed rebleeding is possible after endovasculartreatment.

Özet

Endovascular Treatment of Cerebral Aneurysms During Acute (

🔖

Cite This Article

JIN, H., XIANLI, L., ZHONGXUE, W., QU, R. (2022). Akut Subaraknoid Kanama Sırasında (<72 saat) Serebral Anevrizmaların Endovasküler Tedavisi. Journal of Neurological Sciences (Turkish), Cilt: 29 - Sayı: 3, 535–541. https://ajindex.com/articles/565242

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Alf ke K, Straube T, Dorner L, Mehdorn HM, Jansen O. Treatment of intracranial broadneck aneurysms with a new self -expanding stent and coil embolization. AJNR Am J Neuroradiol 25:584–591, 2004
  2. Akpek S, Arat A, Morsi H, Klucznick RP, Strother CM, Mawad ME. Self expandable stent-assisted coiling of wide-necked intracranial aneurysms: a single-center experience. AJNR Am J Neuroradiol 26: 1223–1231, 2005
  3. Baldi S, Mounayer C, Piotin M, Spelle L, Moret J. Balloon-assisted coil placement in wide-neck bif urcation aneurysms by use of a new, compliant balloon microcatheter. AJNR Am J Neuroradiol 24:1222–1225, 2003
  4. Biondi A, Janardhan V, Katz JM, Salvaggio K, Riina HA, Gobin YP. Neurof orm stentassisted coil embolization of wide-neck intracranial aneurysm: strategies in stent deployment and midterm f ollow- up. Neurosurgery 61:460–469, 2007
  5. CARAT Investigators. Rates of delayed rebleeding f rom intracranial aneurysms are low af ter surgical and endovascular treatment. Stroke 37:1437-42, 2006. 6. dos Santos Souza MP, Agid R, Willinsky RA, et al. Microstent-assisted coiling f or widenecked intracranial aneurysms. Can J Neurol Sci 32:71–81, 2005
  6. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28: 14–19, 1968
  7. Jennett B, Bond M. Assessment of outcome af ter severe brain damage. Lancet 1: 480–484, 1975
  8. Johnston SC, Higashida RT, Barrow DL, et al. Recommendations f or the endovascular treatment of intracranial aneurysms: a statement f or healthcare prof essionals f rom the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology. Stroke 33:2536–2544, 2002
  9. Katsaridis V, Papagiannaki C, Violaris C. Embolization of acutely ruptured and unruptured wide-necked cerebral aneurysms using the Neurof orm2 stent without pretreatment with antiplatelets: a single center experience. AJNR Am J Neuroradiol 27: 1123–1128, 2006
  10. Lylyk P, Ferrario A, Pasbon B, Miranda C, Doroszuk G. Buenos Aires experience with the Neurof orm self -expanding stent f or the treatment of intracranial aneurysms. J Neurosurg 102:235–241, 2005
  11. Mayberg MR, Batj er HH, Dacey R, et al. Guidelines f or the management of aneurismal subarachnoid hemorrhage: a statement f or healthcare prof essionals f rom a special writing group of the Stroke Council, American Heart Association. Stroke 25:2315–2328, 1994
  12. Mericle RA, Wakhloo AK, Rodriguez R, et al. T